Maqui Berry Eye Fatigue Randomized Trial Evidence Table

Structured evidence table for Maqui Berry Eye Fatigue Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Maqui Berry Eye Fatigue Randomized Trial3 4 5 6 7 8 9 10 11 12 , , With changing environmental conditions, such as air conditioners, and dry air, dry eye syndrome has become a public health concern.Several epidemiological studies on Japanese employees,,have revealed that an upsurge in Visual Display Terminal (VDT) work by using a computer, cell phone, and other screen-based devices has increased the risk factor for dry eye syndrome.2Yamashita Shin-ichiro (2019)Effects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
Maqui Berry Eye Fatigue Randomized TrialParticipants who initially scored 5–10 mm/5 min in Schirmer's test (normal: >10 mm) increased at the most 5 mm to be in the normal range.2Yamashita Shin-ichiro (2019)Effects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
Maqui Berry Eye Fatigue Randomized TrialLikewise, neither participants, physicians, assessors of outcomes, nor others associated with the study were aware of the groups or were involved in their allocation.2Yamashita Shin-ichiro (2019)Effects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
Maqui Berry Eye Fatigue Randomized TrialAristotelia chilensis , ® ® ® ® ® Maqui berry () growing in the Patagonia region of Chile is rich in anthocyanins, and has been used as a traditional medicine to treat inflammation since ancient times.Major anthocyanins contained in maqui berry are delphinidin derivatives with potent antioxidant activities.2Yamashita Shin-ichiro (2019)Effects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
topicMaqui Berry Eye Fatigue Randomized Trial
claim3 4 5 6 7 8 9 10 11 12 , , With changing environmental conditions, such as air conditioners, and dry air, dry eye syndrome has become a public health concern.Several epidemiological studies on Japanese employees,,have revealed that an upsurge in Visual Display Terminal (VDT) work by using a computer, cell phone, and other screen-based devices has increased the risk factor for dry eye syndrome.
evidence level2
citationYamashita Shin-ichiro (2019)
sourceEffects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
topicMaqui Berry Eye Fatigue Randomized Trial
claimParticipants who initially scored 5–10 mm/5 min in Schirmer's test (normal: >10 mm) increased at the most 5 mm to be in the normal range.
evidence level2
citationYamashita Shin-ichiro (2019)
sourceEffects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
topicMaqui Berry Eye Fatigue Randomized Trial
claimLikewise, neither participants, physicians, assessors of outcomes, nor others associated with the study were aware of the groups or were involved in their allocation.
evidence level2
citationYamashita Shin-ichiro (2019)
sourceEffects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial
topicMaqui Berry Eye Fatigue Randomized Trial
claimAristotelia chilensis , ® ® ® ® ® Maqui berry () growing in the Patagonia region of Chile is rich in anthocyanins, and has been used as a traditional medicine to treat inflammation since ancient times.Major anthocyanins contained in maqui berry are delphinidin derivatives with potent antioxidant activities.
evidence level2
citationYamashita Shin-ichiro (2019)
sourceEffects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial

Source documents

  1. Effects of MaquiBright ® on improving eye dryness and fatigue in humans: A randomized, double-blind, placebo-controlled trial